Transparency Market Research Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Single User License:
USD 4795 Multi User License:
USD 7795 Corporate User License:
USD 10795
Published Date 01-July-2014
145 Page Report
Request Sample
Buy Now
Press Release
Global Biological Drugs Market is Expected to Reach USD 287,139.7 Million in 2020: Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Biological Drugs Market
REPORT DESCRIPTION
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 According to a new market report published by Transparency Market Research "Biological Drugs Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," the global biological drugs market is estimated at USD 161,056.5 million in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach an estimated value of USD 287,139.7 million in 2020. Browse the full Biological Drugs Market Report at http://www.transparencymarketresearch.com/biological-drugs-market.html The biological drugs market is witnessing a significant growth due to the increasing prevalence of chronic diseases and increase in the global geriatric population. Biological drugs are used in treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Moreover, various government associations are also promoting the usage of biological drugs. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market. On the other hand, high cost of biological drugs and patent expiry of blockbuster drugs impede the growth of the market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints of the market. As a result, biological drugs market is expected to grow a CAGR of about 10.1% during 2014-2020. North America is the largest market for biological drugs. Increased use of biological drugs for the treatment of diseases such as cancer, diabetes and other chronic diseases are supporting the growth of the biological drugs market in the region. The American Center for Biological Medicine (ACBM) is one of the largest biological medicine clinics in the U.S. Similarly, the European biological drugs market is growing rapidly due to increased usage of biological drugs for the treatment of various chronic diseases such as diabetes, cancer and inflammatory diseases. In Asia, low manufacturing cost is attracting many biological manufactures to invest in Asian countries, supporting the growth of the biological drugs market. Moreover, Asian governments are also supporting
Transparency Market Research
2
Biological Drugs Market
growth of the biological drugs market by increased investment on biotech companies for construction of R&D and manufacturing facilities. Request Sample Report From here : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1694 Novartis AG, Pfizer Inc., GlaxoSmithKline plc. and Merck & Co., Inc. are the some of the leading players in the global biological drugs market. Other major players of biological drugs market include Abbott Laboratories, Biogen Idec and Amgen Inc. The global market of biological drugs is segmented as follows: Biological Drugs Market, By Therapeutic Protein
•
Enbrel
•
Lantus
•
Neulasta
•
Avonex
•
NovoLog
•
Rebif
•
Humalog
•
Aranesp
•
Epogen
•
Levemir
•
Victoza
•
Betaseron
Transparency Market Research
3
Biological Drugs Market
•
Neupogen
•
Eylea
Biological Drugs Market, By Monoclonal Antibody (mAb)
•
Humira
•
Remicade
•
Rituxan
•
Avastin
•
Herceptin
•
Lucentis
Biological Drugs Market, By Vaccine
•
Prenvar 13
•
Gardasil
•
Fluzone
•
Varivax
•
Cervarix
Biological Drugs Market, by Geography
•
North America
•
Europe
•
Asia
•
Rest of the World (RoW)
Transparency Market Research
4
Biological Drugs Market
Browse All Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
TABLE OF CONTENT
Chapter 1 Preface 1.1 Report Description 1.2 Research methodology 1.2.1 Sources 1.2.1.1 Secondary Research 1.2.1.2 Primary Research 1.2.1.3 Assumptions
Chapter 2 Executive Summary
Chapter 3 Global Biological Drugs Market – Industry Analysis 3.1 Introduction 3.2 Market Drivers 3.2.1 Increasing prevalence of chronic diseases enhance the market growth 3.2.2 Globally geriatric population increases the demand of biological drugs 3.2.3 Various government associations are promoting usage of biological drugs 3.3 Market Opportunities
Transparency Market Research
5
Biological Drugs Market
3.3.1 Advancement in biomedical science promises to boost the development of new biological products 3.4 Restraints 3.4.1 High cost of biological drugs impedes market growth 3.4.2 Patent expiration of various blockbuster biological drugs 3.4.3 Risk of adverse effects associated with biological injectable medicines
Chapter 4 Market Trends 4.1.1 Increasing use of anti-Vascular Endothelial Growth Factor (VEGF) therapy is gaining popularity in biopharmaceutical industry 4.1.2 Genetically Modified Organisms (GMOs) are gaining importance in biological drugs market
Related & Recently Published Reports by Transparency Market Research Drugs of Abuse Testing Market: http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html Ophthalmic Drugs Market: http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html
Chapter 5 Porter’s Five Forces Analysis 5.1.1 Bargaining power of suppliers 5.1.2 Bargaining power of buyers 5.1.3 Threat of new entrants
Transparency Market Research
6
Biological Drugs Market
5.1.4 Threat of substitutes 5.1.5 Degree of competition
Chapter 6 Global Market Size and Forecast
Chapter 7 Segment Analysis, by Therapeutic Protein 7.1 Enbrel 7.2 Lantus 7.3 Neulasta 7.4 Avonex 7.5 NovoLog 7.6 Rebif 7.7 Humalog 7.8 Aranesp 7.9 Epogen 7.10 Levemir 7.11 Victoza 7.12 Betaseron 7.13 Neupogen 7.14 Eylea
Transparency Market Research
7
Biological Drugs Market
Chapter 8 Segment Analysis, by mAb 8.1 Humira 8.2 Remicade 8.3 Rituxan 8.4 Avastin 8.5 Herceptin 8.6 Lucentis Browse the full Biological Drugs Market Report at http://www.transparencymarketresearch.com/biological-drugs-market.html
Chapter 9 Segment Analysis, by Vaccine 9.1 Prenvar 13 9.2 Gardasil 9.3 Fluzone 9.4 Varivax 9.5 Cervarix
Chapter 10 Regional Analysis 10.1 Scenario in North America 10.2 Scenario in Europe
Transparency Market Research
8
Biological Drugs Market
10.3 Scenario in Asia 10.4 Rest of the World (RoW)
Chapter 11 Pipeline Biologic Drugs 11.1 Biological drugs under development for auto-immune diseases 11.2 Biological drugs under development for blood diseases 11.3 Biological drugs under development for cancer and related conditions 11.4 Biological drugs under development for diabetes and cardiovascular diseases
Chapter 12 Competitive Landscape
Chapter 13 Company Profiles 13.1 Pfizer Inc. 13.1.1 Company Overview 13.1.2 Product & Segments 13.1.3 Financial Performance 13.1.4 Strategic Developments 13.2 Abbott Laboratories 13.2.1 Company Overview 13.2.2 Product & Segments 13.2.3 Financial Performance
Transparency Market Research
9
Biological Drugs Market
13.2.4 Strategic Developments 13.3 Novartis AG 13.3.1 Company Overview 13.3.2 Product & Segments 13.3.3 Financial Performance 13.3.4 Strategic Developments 13.4 Eli Lilly and Company 13.4.1 Company Overview 13.4.2 Product & Segments 13.4.3 Financial Performance 13.4.4 Strategic Developments 13.5 GlaxoSmithKline plc. 13.5.1 Company Overview 13.5.2 Product & Segments 13.5.3 Financial Performance 13.5.4 Strategic Developments 13.6 Bristol-Myers Squibb Company 13.6.1 Company Overview 13.6.2 Product & Segments 13.6.3 Financial Performance 13.6.4 Strategic Developments 13.7 Merck & Co., Inc.
Transparency Market Research
10
Biological Drugs Market
13.7.1 Company Overview 13.7.2 Product & Segments 13.7.3 Financial Performance 13.7.4 Strategic Developments 13.8 Amgen Inc. 13.8.1 Company Overview 13.8.2 Product & Segments 13.8.3 Financial Performance 13.8.4 Strategic Developments 13.9 Baxter International Inc. 13.9.1 Company Overview 13.9.2 Product & Segments 13.9.3 Financial Performance 13.9.4 Strategic Developments 13.10 Biogen Idec 13.10.1 Company Overview 13.10.2 Product & Segments 13.10.3 Financial Performance 13.10.4 Strategic Developments
Browse the full Biological Drugs Market Report at http://www.transparencymarketresearch.com/biological-drugs-market.html
Transparency Market Research
11
Biological Drugs Market
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
12